Author:
Ganesan Alagammai,Arunagiri Thirumalai,Mani Suganandhini,Kumaran Vamsi Ravi,SK Gayathrii,Elumalai Sandhiya,Kannaiah Kanaka Parvathi,Chanduluru Hemanth Kumar
Publisher
Springer Science and Business Media LLC
Reference112 articles.
1. 2022-24 Mpox (monkeypox) outbreak: global trends (2024). Available at: https://worldhealthorg.shinyapps.io/mpx_global/ (Accessed: 6 August 2024)
2. 2022-24 Mpox outbreak: global trends (2024). Available at: https://worldhealthorg.shinyapps.io/mpx_global/ (Accessed: 6 August 2024)
3. A clinical study investigating the safety and immune responses after immunization with investigational monkeypox vaccines (2024). Available at: https://classic.clinicaltrials.gov/ct2/show/NCT05988203 (Accessed: 13 May 2024)
4. Adler H et al (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22(8):1153–1162. https://doi.org/10.1016/S1473-3099(22)00228-6
5. Ahmed SF et al (2022) Vaccinia-virus-based vaccines are expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus. Viruses 14(9):1960. https://doi.org/10.3390/v14091960